| Dr Rodolfo Bonatti, MD | |
|
2226 Nelson Hwy Ste 200, Chapel Hill, NC 27517-9638 | |
| (984) 974-2020 | |
| Not Available |
| Full Name | Dr Rodolfo Bonatti |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Location | 2226 Nelson Hwy Ste 200, Chapel Hill, North Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437920329 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207WX0009X | Ophthalmology - Glaucoma Specialist | 2023-02021 (North Carolina) | Secondary |
| 207W00000X | Ophthalmology | 2023-02021 (North Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rodolfo Bonatti, MD 5221 Paramount Pkwy Ste 420, Morrisville, NC 27560-5491 Ph: () - | Dr Rodolfo Bonatti, MD 2226 Nelson Hwy Ste 200, Chapel Hill, NC 27517-9638 Ph: (984) 974-2020 |
News Archive
The University of Illinois at Chicago has been selected as one of six research centers in the U.S. to help develop a comprehensive new strategy to control Ebola and other emerging infectious diseases in health facilities.
ALK rearrangement has been found in 9.6% of lung cancer patients tested in the Lung Cancer Mutation Consortium, and MET amplification in another 4.1%, reflecting how many patients might benefit from targeted therapies such as crizotinib, according to research presented at the 14th World Conference on Lung Cancer in Amsterdam, hosted by the International Association for the Study of Lung Cancer.
In a new scientific breakthrough, researchers have taken skin cells from a patient with liver disease and turned them into replacement liver cells. Although the procedure is years before it can be used in humans, but if approved, it could launch a new era of personalized therapies for serious genetic disorders.
BioInvent International AB announced today that the first patient has been treated in an open, dose-escalation phase I study of the company's antibody BI-505 for patients with advanced multiple myeloma.
› Verified 7 days ago
Alexis Renee Pascoe, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 2226 Nelson Hwy Ste 200, Chapel Hill, NC 27517 Phone: 984-974-2020 | |
Dr. Paul Singer, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 101 Manning Dr, Chapel Hill, NC 27599 Phone: 919-966-4131 | |
Dr. Donald L Budenz, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5151 Bioinformatics, Cb 7040, Chapel Hill, NC 27599 Phone: 919-843-0297 | |
Christopher Jaeyon Hwang, MD, MPH Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2226 Nelson Hwy Ste 200, Chapel Hill, NC 27517 Phone: 984-974-2020 | |
Kathleen G Gordon, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: Unc Ch Department Of Ophthalmology, 130mason Farm Rd, 5151 Bioinformatics, Chapel Hill, NC 27599 Phone: 919-966-5296 Fax: 919-966-1908 | |
Dr. Rachel A Tesser, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 55 Vilcom Center Circle, Suite 110, Chapel Hill, NC 27514 Phone: 919-960-2720 Fax: 919-960-2721 | |
Steven Brent Flynn, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2226 Nelson Hwy Ste 200, Chapel Hill, NC 27517 Phone: 984-974-2020 |